Pharmaceutical and Device – Policy & Medicine

Teva Pharmaceuticals Fined €462.6 Million Over Anti-Competitive Practices in the EU

James Comer Calls on PBM Executives to Revise Testimony Presented to Congress

FTC Issues Interim Report on Pharmacy Benefit Managers

PhRMA Submits Comments on 340B Program Stability

Adding Requirements to Buprenorphine Prescribers Increased Prescriptions?

Study Finds that Physicians Receiving Remuneration Were More Likely to Give Hyaluronic Acid Injections Under Medicare Part B

FTC Deepens Probe into Pharmacy Benefit Managers

Senate Finance Committee Releases Framework for PBM Solutions

PatientView Releases 2022 Patient Group Survey on Pharmaceutical Industry

PhRMA Focuses on Other Important Health Care System Improvements